What is SANDOSTATIN LAR used for?1
SANDOSTATIN LAR is indicated for the treatment of:
- Patients with acromegaly in whom surgery is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective. ...Show more [1]
What is SANDOSTATIN LAR used for?1SANDOSTATIN LAR is indicated for the treatment of:
|
...Show more [2] |
|
...Show more [4] |
__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________...Show more [5] |
What is Sandostatin® LAR® (octreotide acetate) used for?
SANDOSTATIN LAR is indicated for the treatment of:
|
...Show more [7] |
More informationSummary of product characteristics (SPC) for Lucentis Great Britain [9] and ...Show more [8] |
Heart failure [10]...Show more [10] |
...Show more [11] |
Gilenya®▼(fingolimod) [12]More informationSummary of product characteristics (SPC) [13]for Gilenya This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis...Show more [12] |
Summary of product characteristics (SmPC) for Cosentyx Great Britain [15] and Northern Ireland [16] ...Show more [14] |
Summary of product characteristics (SmPC) for Cosentyx Great Britain [15] and Northern Ireland [16] ...Show more [17] |
Aimovig® (erenumab) [18]Where can I get more information about this medicine?Great Britain (GB) Summary of Product Characteristics (SmPC) [19] for Aimovig |
|
What is advanced breast cancer (aBC)? ...Show more [22] |
...Show more [23] |
More information For more information about Rydapt please consult: Summary of product characteristics (SmPC) GB [25] for Rydapt |
|
Links
[1] https://prod.health.novartis.co.uk/public/medicines/oncology/sandostatin-lar
[2] https://prod.health.novartis.co.uk/medicines/haematology/scemblix
[3] https://prod.health.novartis.co.uk/resources-and-training/neuroscience/therapy-area/physician-patient-interaction-tools
[4] https://prod.health.novartis.co.uk/medicines/rare-diseases/ilaris
[5] https://prod.health.novartis.co.uk/public/medicines/neuroscience/kesimpta
[6] https://prod.health.novartis.co.uk/medicines/oncology/sandostatin-lar
[7] https://prod.health.novartis.co.uk/medicines/cardio-metabolic/inclisiran
[8] https://prod.health.novartis.co.uk/public/medicines/ophthalmology/lucentis
[9] https://www.medicines.org.uk/emc/product/5418/smpc
[10] https://prod.health.novartis.co.uk/therapy-areas/cardio-metabolic/heart-failure
[11] https://prod.health.novartis.co.uk/therapy-areas/ophthalmology/inherited-retinal-dystrophies
[12] https://prod.health.novartis.co.uk/public/medicines/neuroscience/gilenya
[13] https://www.medicines.org.uk/emc/product/4545/smpc
[14] https://prod.health.novartis.co.uk/public/medicines/rheumatology/cosentyx
[15] https://www.medicines.org.uk/emc/search?q=cosentyx
[16] https://www.emcmedicines.com/en-gb/northernireland/medicines?search=cosentyx
[17] https://prod.health.novartis.co.uk/public/medicines/dermatology/cosentyx
[18] https://prod.health.novartis.co.uk/public/medicines/neuroscience/aimovig
[19] https://www.medicines.org.uk/emc/product/9380/smpc
[20] https://prod.health.novartis.co.uk/public/medicines/oncology/tafinlar-mekinist
[21] https://www.medicines.org.uk/emc/product/5190/smpc
[22] https://prod.health.novartis.co.uk/therapy-areas/oncology/advanced-breast-cancer
[23] https://prod.health.novartis.co.uk/medicines/cardio-metabolic/entresto
[24] https://prod.health.novartis.co.uk/public/medicines/haematology/rydapt
[25] https://www.medicines.org.uk/emc/product/9134/smpc
[26] https://prod.health.novartis.co.uk/medicines/oncology/tafinlar-mekinist/melanoma